"Renowned Nephrologist providing complete renal care for kidney and transplant patients. Easily accessible office with our own infusion suite and Baystate labs right next door."

During the past decade, Renal and Transplant Associates of New England, PC conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 16 clinical trials were completed, i.e. on average, 69.6% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 8 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Renal and Transplant Associates of New England, PC" #1 sponsor was "Keryx Biopharmaceuticals" with 4 trials, followed by "Bristol-Myers Squibb" with 3 trials sponsored, "C. R. Bard" with 3 trials sponsored, "Bayer" with 2 trials sponsored and "Goldfinch Bio, Inc." with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Renal and Transplant Associates of New England, PC" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Collaborative Study Group (CSG)" with 1 trials as a collaborator, "Medical Nutrition USA, Inc." with 1 trials as a collaborator, "Medstar Health Research Institute" with 1 trials as a collaborator and "Mountain Kidney and Hypertension Associates" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Renal and Transplant Associates of New England, PC" are "Hyperphosphatemia" (4 trials), "Chronic Kidney Disease" (3 trials), "Glomerulosclerosis, Focal Segmental" (3 trials), "Pruritus" (3 trials) and "Uremic Pruritus" (3 trials). Many other conditions were trialed in "Renal and Transplant Associates of New England, PC" in a lesser frequency.

Most popular intervention types in "Renal and Transplant Associates of New England, PC" are "Drug" (26 trials), "Device" (4 trials), "Other" (4 trials), "Behavioral" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "ferric citrate" (3 trials), "Placebo oral capsule" (2 trials), "VX-147" (2 trials) and "0.9% sodium chloride solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Renal and Transplant Associates of New England, PC" are 36 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Renal and Transplant Associates of New England, PC". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Renal and Transplant Associates of New England, PC, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Renal and Transplant Associates of New England, PC, 4 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".